CRP and juvenile polyposis syndrome: Optimal clinical decision limits for the SF-CRP have been demonstrated to vary depending on the assay format [2,7,8,10-24], supporting the need for a clinical validation of an assay-specific clinical decision limit by each laboratory offering the test for the diagnosis of PJI.